Open Access

Low plasma vitamin A concentration is associated with tuberculosis in Moroccan population: a preliminary case control study

  • Mounia Qrafli1, 2,
  • Khalid El Kari1,
  • Hassan Aguenaou1,
  • Jamal Eddine Bourkadi3,
  • Khalid Sadki2 and
  • Mohammed El Mzibri1Email author
BMC Research Notes201710:421

https://doi.org/10.1186/s13104-017-2737-z

Received: 30 November 2016

Accepted: 6 August 2017

Published: 23 August 2017

Abstract

Background

Vitamin A plays numerous roles in immune system. Its deficiency alters both the innate and adaptive immunity. Previous results reported that the micronutrients deficiency, particularly vitamin A, is observed in patients with tuberculosis. Thus, we aimed in this study to assess vitamin A concentrations in Moroccan patients with tuberculosis to set up a large efficacy study of vitamin A supplementation for TB infected patients. Plasma retinol concentration was measured by HPLC in 44 recently diagnosed TB patients and 40 healthy controls.

Results

We showed that plasma vitamin A is significantly lower in tuberculosis patients as compared to healthy controls (p < 0.0001). Moreover, no significant association was found between vitamin A deficiency and, TB severity and patients’ ages.

Conclusion

Our study confirms the association between low vitamin A levels and tuberculosis disease.

Keywords

Tuberculosis Vitamin A Plasma Deficiency Morocco

Background

Tuberculosis, an infectious disease caused by Mycobacterium tuberculosis (MTB) is still a health problem causing human mortality worldwide. According to the World Health Organization (WHO) report, One-third of the world’s population is reportedly infected with MTB and 9.6 million new tuberculosis (TB) cases and about 1.5 million deaths were reported this year [1]. An overwhelming majority of TB patients reside in the developing countries, which suffer from marked poverty, lack of healthy living conditions, and inadequate medical facilities [2]. TB development is closely dependent on the immunological status of the hosts, requiring the presence of micronutrients including iron, zinc, vitamins A and D for adequate functioning [3, 4]. Vitamin A has a pivotal role in immune responses and accordingly is essential in the host defense against pathogens as MTB [5, 6]. Hall and his colleagues have reported that Th1 and Th17 immune responses are impaired in the absence of vitamin A metabolites as demonstrated by the observation of the low level of IFN-γ and IL17 cytokines production after infection of vitamin A deficient mice with T. gondii [7]. Indeed, the authors of this study have also demonstrated that RA restores the level of these cytokines production and therefore influences significantly the CD4 T cells protective immunity [7].

More recently, RA signaling was shown to confer Th1 cell stability and to restrain their conversion to Th17 cells [8]. In addition, it has been reported that tryptophan-aspartate containing coat protein (TACO) gene plays a crucial role allowing mycobacteria to survive within macrophages while synergistic actions of retinoic acid (RA) and vitamin D are able to down-regulate TACO transcription in human macrophages allowing delivery of Mycobacteria to lysosomes [911]. Furthermore, when THP-1 macrophages are exposed to chenodeoxycholic acid/RA, the entry and intracellular survival of MTB are significantly restricted [12]. Moreover, oral administration of RA decreases the number of colony-forming units (CFU) of MTB in RA-treated rats compared with controls [13].

More recently, an interesting finding revealed that expression of NPC2 and vitamin A-mediated antimicrobial activity against MTB triggered a reduction in the total cellular cholesterol concentration [14].

Conversely, vitamin A deficiency (VAD) is associated with alterations in ocular tract including squamous metaplasia of the conjunctiva and cornea, in addition to keratinization and loss of cilia in the respiratory tract. Moreover, VAD is also linked to a loss of microvilli from gastrointestinal tract and a decrease in goblet cells and mucin production of genitourinary tract [1520]. It has also been reported that VAD disrupts normal neutrophil and macrophage development and can result in impaired ability to ingest and kill bacteria [21, 22]. A high prevalence of (VAD) has been observed in patients with pulmonary tuberculosis, suggesting a strong association between vitamin A deficiency and TB development [2325].

In Morocco, TB is considered as a major problem of the public health with a high incidence reaching, in 2014, 82 new cases for 100,000 inhabitants. Tuberculosis affects especially young adults and therefore has a high impact on the socio-economic status of the country. To fight against TB, the ministry of health has set up a national tuberculosis program focusing its interest on rapid diagnosis and adequate management of TB patients [26]. However, the national program is faced by many factors including the virulence of the bacteria, resistance to available anti-tuberculosis drugs, adherence to the treatment and the presence of malnutrition, especially micronutrients deficiency which has a dramatic impact on the immune status of patients. Therefore, modulation of the immune system of TB patients, through vitamin A supplementation, could be of a great interest to increase the rate of sputum conversion, enhance the wellbeing of TB patients and consequently help the program to fight against TB. Evaluation of vitamin A status of TB patients is primordial prior to the implementation of a nutritional strategy based on vitamin A supplementation of TB patients for better management of TB in Morocco. Thus, the present study was planned to evaluate plasma retinol concentrations in Moroccan newly diagnosed pulmonary TB patients compared to healthy controls.

Methods

Subjects and study design

The present study was conducted on 84 participants; 44 TB patients and 40 healthy controls. TB patients were recruited from Moulay Youssef hospital in Rabat, specialized in TB diagnosis and treatment. To be included in the study, patients have to be new TB cases and should be sputum-smear and/or culture positive. According to guidelines of the National tuberculosis program, the disease is considered as severe when it takes the form of miliary TB, multifocal TB, extended tuberculosis bronchopneumonia and in case of confection TB/HIV.

Healthy controls group was recruited from the Regional Center of Blood Transfusion of Rabat and all of them are tuberculin skin test negative. All TB patients and healthy controls recruited in this study were HIV seronegative. HIV testing was done using rapid test (Determine™ HIV-1/2 antibody test). At recruitment, each participant was assessed, using questionnaires including age, sex and medical history. Blood samples were obtained from all eligible subjects, both patients and controls, for plasma retinol evaluation.

Blood collection

Approximately, 5 mL of the whole blood was taken by venipuncture into 5 mL vacutainers (Greiner Bio-One, Germany) containing EDTA. To avoid direct exposition to light, specimens were transported in cryoboxes. Plasma was separated after centrifugation of blood at 750g for 10 min at room temperature, and then stored at −80 °C until analysis.

Plasma retinol analysis

Plasma retinol concentration was measured by HPLC (High Performance Liquid Chromatography) as previously described [27]. Briefly, 0.5 mL of serum was mixed with 0.5 mL of ethanol containing internal standard (retinyl acetate), vortexed and extracted twice with 2 mL of methylene chloride–hexane (1:5). Organic phases were pooled, evaporated to dryness and reconstituted to be injected onto the HPLC (20 μL). The retinol was measured using a Spheri-5-ODScolumn (Applied Biosystems, San Jose, CA) with mobile phase of acetonitrile–methanol (85:15). The reading was done at 326 nm using an UV–Vis detector (Model 490, Waters Associates, Milford, MA, USA). VAD was defined as plasma retinol concentration less than 0.70 mmol/L [28, 29].

Quality control of plasma retinol analysis

The plasma retinol was measured in the laboratory of theUnitéMixte de Recherche Nutrition et Alimentation (CNESTENUniversitéIbnTofaïl), Rabat, Morocco. The precision and accuracy of the analytical method were checked periodically by the use of certified reference materials 968d (Fat-soluble Vitamins, carotenoids and cholesterol in Human Serum) from National Institute of Standard and Technology (Lot No H-479, NIST; Gaithersburg, MD, USA). The analysis of reference material showed a loss of 5% during the extractions that was considered in the calculation of serum retinol concentrations.

Otherwise, an in-house reference material (IHRM) was used (378.9 ± 3.64 µg/L). Accordingly, after 20 analysed serum samples, one IHRM sample was analysed and a Shewhart was plotted. All IHRM retinol values during the analytical period were between ±2SD. Moreover, the overall CV for the mean retinol concentration of the in-house control plasma was 0.7% within-day [Min = 0.328, Max = 1.056] and 0.988% between days.

Statistical analysis

Differences in means between normally distributed parameters were tested using the independent student-t test. However, the retinol variable did not follow a normal distribution that’s why the median and [Min–Max] were added to the table. Mann–Whitney test was used for the comparison and differences were considered statistically significant for p values ≤0.05.

Results

Demographic and clinical characteristics of participants are reported in Table 1. The mean age for TB patients was 31.02 ± 12 years, ranging from 18 to 52 years, whereas for healthy controls, the mean age was 38.6 ± 11.5 years, ranging from 21 to 58 years. The sex ratio (male/female) was 29/15 (1.93) and 21/19 (1.11) for TB patients and healthy controls, respectively.
Table 1

Demographic and clinical characteristics of TB patients and healthy controls

Variables

TB patients (N = 44)

Healthy controls (N = 40)

Age (mean ± SD)

31.02 ± 12.04

38.6 ± 11.5

Gender, number (%)

 Men

29 (59.1)

21 (52.5)

 Women

15 (34.1)

19 (47.5)

HIV status

Negative

Negative

Clinical feature, number (%)

 Hemoptysis

16 (36.4)

Absence of symptoms

 Expectoration

16 (36.4)

 Fever

12 (27.3)

 Cough

14 (31.8)

 Weight loss

37 (84.1)

 Abnormality shown by chest X-ray examination number (%)

37 (84.1)

Overall, 84.1% of TB patients exhibited an abnormal chest X-ray and had a weight loss. Clinical symptoms were also reported. The most common symptoms were hemoptysis and expectoration, reported in 36.4% of patients, while chronic cough and fever were reported respectively in 31.8 and 27.3% of patients.

Plasma retinol concentration was assessed in both TB patients and healthy controls. Overall, the mean plasma retinol concentration was 1.74 ± 1.09 µmol/L in TB patients and 2.8 ± 0.97 µmol/L in healthy controls (Table 2). Comparison between TB patients and healthy controls showed a statistically significant difference (p < 0.0001).
Table 2

Vitamin A status of TB patients and healthy controls

Variable

All TB patients (N = 44)

Healthy controls (N = 40)

p

Mean retinol (µmol/L)

1.72 ± 1.09

2.8 ± 0.97

<0.0001

Median

1.40

2.55

Minimum

0.452

1.122

Maximum

4.945

5.394

Distribution of plasma retinol concentration according to sex was also assessed and is reported in Table 3. No statistically significant difference was observed between men and women in both patients and healthy groups (p > 0.05). Interestingly, plasma retinol concentration was lower in TB women as compared to healthy women (p = 0.04275). Moreover, a strong statistically significant difference was recorded in TB men compared to healthy men (p < 0.0001).
Table 3

Distribution of plasma retinol concentration according to sex and age

 

TB patients

Healthy controls

p

N

Mean retinol (µmol/L)

Median [Min–Max]

N

Mean retinol (µmol/L)

Median [Min–Max]

Sex

 Men

29

1.60 ± 0.8

21

2.87 ± 1.01

<0.0001

1.45 [0.45–3.89]

2.54 [1, 39]

 Women

15

1.94 ± 1.52

19

2.69 ± 0.93

0.04275

1.22 [0.55–4.94]

2.56 [1.12–4.73]

  

p > 0.05

 

p > 0.05

 

Age (years)

 <29

23

1.86 ± 1.18

10

2.93 ± 0.88

<0.001

1.45 [0.53–4.94]

2.62 [2.04–4.32]

 30–49

15

1.66 ± 1.12

19

2.98 ± 1.05

0.0014

1.24 [0.45–4.01]

2.56 [1.17–5.39]

 >50

6

1.32 ± 0.57

11

2.30 ± 0.77

0.01

1.24 [0.45–4.01]

2.32 [1.12–3.27]

  

p > 0.05

 

p > 0.05

 

Distribution of plasma retinol concentration according to age was assessed in both patients and healthy groups (Table 3). Results clearly showed that plasma retinol concentration is significantly lower in patients compared to healthy controls in the three age groups. However no significant differences have been observed among the different age categories within the same group: TB patients or the healthy controls (p > 0.05).

According to clinical examination and chest ray interpretation, 59% of TB patients have mild TB (26/44) and 41% have severe TB (18/44). Both patients with mild and severe TB exhibited low levels of plasma retinol as compared to healthy controls. Comparison of plasma retinol concentration between patients with mild and severe TB showed no statistical difference (p > 0.05) (Table 4).
Table 4

Comparison of plasma retinol concentrations in patients with mild and severe TB

Variable

TB patients with

p

Severe TB (n = 18)

Mild TB (n = 26)

Mean retinol (µmol/L)

1.49 ± 0.86

1.87 ± 1.22

0.2614

Median [Min–Max]

1.29 [0.45–4.01]

1.40 [0.53–4.94]

Discussion

Vitamin A is essential for normal visual function, growth, reproduction, hematopoiesis, and immunity [18]. It can be obtained as retinyl palmitate, from dietary animal sources (liver, fish liver oils, eggs, and dairy products), and as carotenoids from vegetables (dark-green leafy vegetables and deep-orange fruits), which can be converted to retinoid within the intestine and other tissues. Metabolism of vitamin A results in the production of three major metabolites: retinol, retinaldehyde and retinoic acid (RA) [30]. RA is recognized as a principal regulatory retinoid implicated in the regulation of more than 500 genes [31], while retinaldehyde plays a unique role as the chromophore of the visual pigment rhodopsin [32, 33].

In Morocco, the vitamin A supplementation strategy is a part of a national program set up by the ministry of health, and is widely used to restore retinol status of women in post-partum and in case of severe infection, like measles. Accordingly, we have planned to evaluate the benefits of vitamin A supplementation when added to treatment of TB patients. As a first step of this evaluation, the assessment of plasma retinol in TB patients compared to healthy controls is necessary.

In this study, plasma retinol concentrations were significantly lower in TB patients than in controls, which is in phase with many studies conducted in different countries. Indeed, epidemiological evidence demonstrates an association between vitamin A and tuberculosis, and usually plasma vitamin A levels are significantly higher in healthy controls compared to tuberculosis patients [23, 24, 3438].

It’s widely accepted that TB is the major poverty related disease and malnutrition increases susceptibility to MTB infection and the severity of the disease [39].

Low levels of plasma retinol observed in TB patients is well discussed and can result from a number of factors, including the decreased intake caused by the loss of appetite in TB patients [37] and the urinary loss that contributes significantly in lowering serum retinol levels in severe infections, which becomes more important in case of fever [4042]. Moreover, plasma retinol concentration is also affected by the inflammatory status of patients. Indeed, biological evidence clearly showed that transient change in serum retinol levels is also affected by the acute phase response (APR). During the APR, the transcription and translation of positive acute-phase proteins [e.g. C-reactive protein (CRP)] are increased and positive acute phase protein concentrations correlate negatively with serum retinol concentrations [43]. In pulmonary tuberculosis, elevation of CRP is detected and a high CRP is clearly associated with more severe disease [35]. On the other hand, retinol binding protein (RBP) is the principal transport protein for delivering vitamin A from liver stores to peripheral tissues and during the APR, its production is largely decreased affecting the plasma retinol concentration [44].

Of particular interest, the use of plasma retinol evaluation as a marker in the assessment of vitamin A status is controversial. Indeed, transient changes in serum retinol that occur during the APR do not reflect changes in liver reserves and therefore, plasma retinol concentrations cannot be an adequate method to assess vitamin A status during an active APR [21, 45, 46]. Other approaches using labeled vitamin A with stable isotopes (13C-retinol dilution test) are widely recommended to evaluate vitamin A status giving information on plasma retinol concentration and liver stores [46].

Moreover, this study showed no significant difference between plasma retinol concentration, and the severity of TB (p = 0.2614) and the age of TB patients (p > 0.05). Few studies have explored the correlation between VAD and TB severity, among which, Pakasi and coll. have clearly shown that vitamin A was significantly lower in severe TB than in mild TB [37]. This divergence could be explained by the clinical definition of mild/severe TB and the classification criteria, as there’s no biological parameter for such stratification. Regrading the correlation of VAD with patients age, our results are in concordance with pervious reported data [47]. Interestingly, vitamin concentration is lower in TB age groups as compared to the corresponding healthy groups, and this difference is less pronounced in patients aged over 50 years, that could be due to recurrent malnutrition and decreased food intake related to elder age. In fact, recent studies reported that malnutrition and risk of malnutrition are highly prevalent among the old adults [48, 49].

Moreover, we reported here that plasma retinol concentration is lower in both men and women TB patients as compared to men and women healthy controls, respectively, and the difference is more pronounced in men. In this context, it is commonly reported that males are more vulnerable to VAD than females [18, 5052]. On the other hand, worldwide epidemiological data reported that the majority of TB patients are males [42, 43]. Recent finding revealed that sex hormones could be a significant factor for this sex discrimination [5355]. Indeed, testosterone is immunosuppressive and impairs the macrophages activation [56], while the estrogens are pro-inflammatory mediators able to induce the production of TNF-α and stimulate secretion of INF-γ [57, 58]. Keeping that in view, we can suggest that low plasma concentrations of vitamin A in male TB patients may rely on sex hormones, by analogy to data reported about estrogen which might regulate vitamin D3 metabolism [59].

Conclusion

This study clearly showed that TB patients exhibit low concentrations of plasma retinol as compared to healthy controls and VAD could be considered as a risk factor influencing infection with MTB, the development and the severity of the disease. Hence, vitamin A supplementation may be a potential strategy to increase the host immunity and enhance treatment efficacy. Moreover, other approaches, such as food fortification and nutritional education, could be considered as a good strategy to prevent VAD in the whole population and therefore stimulates an effective response against TB development. Finally, further studies are required in this field to demonstrate deeply the role of Vitamin A in boosting immune system in TB patients.

Abbreviations

MTB

Mycobacterium tuberculosis

TB: 

tuberculosis

RA: 

retinoic-acid

TACO: 

tryptophan-aspartate containing coat protein

VAD: 

vitamin A deficiency

HPLC: 

high performance liquid chromatography

APR: 

acute phase response

CRP: 

C-reactive protein

RBP: 

retinol binding protein

INF-γ: 

interferon-gamma

TNF-α: 

tumor necrosis factor-alpha

Declarations

Authors’ contributions

MQ participated in sampling, dosage of vitamin A, data analysis and drafted the manuscript; KEK participated in the design of the project, vitamin A assessment and data analysis; HA participated in the conception and design of the study and review of the final manuscript; JEB was in charge of patient recruitment and clinical evaluation; KS participated in the conception and design of the study and review of the final manuscript; MEM participated in the design and coordination of the project and review of the final manuscript. All authors read and approved the final manuscript.

Acknowledgements

We would like to thank all patients and healthy controls for their participation. We are sincerely grateful to the clinicians and nurses of Moulay Youssef university hospital and the Regional Center of Blood Transfusion (RCBT) of Rabat for their collaboration in this study.

Competing interests

The authors declare that they have no competing interests.

Availability of data and materials

The dataset of the current study is available from the corresponding author at a reasonable request.

Consent for publication

Not applicable.

Ethics approval and consent to participate

The study protocol was approved by the Ethical Committee for Biomedical Research, School of Medicine and Pharmacy, Mohammed V University of Rabat, and a written informed consent was obtained from each study subject.

Funding

The authors declare that no funding was received from any funding agency.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Unité Mixte de Recherche Nutrition et Alimentation, (CNESTEN–Université Ibn Tofaïl)
(2)
Laboratoire de Biochimie-Immunologie, Faculté des Sciences
(3)
Service de Pneumo-Phtisiologie, Hospital Moulay Youssef, CHU Rabat

References

  1. WHO. WHO | Global tuberculosis report 2015. WHO. 2015. http://www.who.int/tb/publications/global_report/en/. Accessed 4 Oct 2016.
  2. WHO. 2007 Tuerculosis facts. 2007. http://www.who.int/tb/publications/2007/factsheet_2007.pdf. Accessed 16 Aug 2017.
  3. Chandra RK. Nutrition and the immune system: an introduction. Am J Clin Nutr. 1997;66:460S–3S.PubMedGoogle Scholar
  4. Katona P, Katona-Apte J. The Interaction between Nutrition and Infection. Clin Infect Dis. 2008;46:1582–8.View ArticlePubMedGoogle Scholar
  5. Guo Y, Brown C, Ortiz C, Noelle RJ. Leukocyte homing, fate, and function are controlled by retinoic acid. Physiol Rev. 2015;95:125–48.View ArticlePubMedPubMed CentralGoogle Scholar
  6. Raverdeau M, Mills KHG. Modulation of T cell and innate immune responses by retinoic Acid. J Immunol Baltim Md. 1950;2014(192):2953–8.Google Scholar
  7. Hall JA, Cannons JL, Grainger JR, Santos LMD, Hand TW, Naik S, et al. Essential role for retinoic acid in the promotion of CD4+T cell effector responses via retinoic acid receptor alpha. Immunity. 2011;34:435–47.View ArticlePubMedPubMed CentralGoogle Scholar
  8. Brown CC, Esterhazy D, Sarde A, London M, Pullabhatla V, Osma-Garcia I, et al. Retinoic acid is essential for Th1 cell lineage stability and prevents transition to a Th17 cell program. Immunity. 2015;42:499–511.View ArticlePubMedPubMed CentralGoogle Scholar
  9. Anand PK, Kaul D, Sharma M. Synergistic action of vitamin D and retinoic acid restricts invasion of macrophages by pathogenic mycobacteria. J Microbiol Immunol Infect Wei Mian Yu Gan Ran Za Zhi. 2008;41:17–25.PubMedGoogle Scholar
  10. Ferrari G, Langen H, Naito M, Pieters J. A coat protein on phagosomes involved in the intracellular survival of mycobacteria. Cell. 1999;97:435–47.View ArticlePubMedGoogle Scholar
  11. Gogulamudi VR, Dubey ML, Kaul D, Atluri VSR, Sehgal R. Downregulation of host tryptophan-aspartate containing coat (TACO) gene restricts the entry and survival of Leishmania donovani in human macrophage model. Front Microbiol. 2015;6:946.View ArticlePubMedPubMed CentralGoogle Scholar
  12. Anand PK, Kaul D. Downregulation of TACO gene transcription restricts mycobacterial entry/survival within human macrophages. FEMS Microbiol Lett. 2005;250:137–44.View ArticlePubMedGoogle Scholar
  13. Yamada H, Mizuno S, Ross AC, Sugawara I. Retinoic acid therapy attenuates the severity of tuberculosis while altering lymphocyte and macrophage numbers and cytokine expression in rats infected with Mycobacterium tuberculosis. J Nutr. 2007;137:2696–700.PubMedPubMed CentralGoogle Scholar
  14. Wheelwright M, Kim EW, Inkeles MS, De Leon A, Pellegrini M, Krutzik SR, et al. All-trans retinoic acid-triggered antimicrobial activity against Mycobacterium tuberculosis is dependent on NPC2. J Immunol Baltim Md. 1950;2014(192):2280–90.Google Scholar
  15. McDowell EM, Keenan KP, Huang M. Effects of vitamin A-deprivation on hamster tracheal epithelium. A quantitative morphologic study. Virchows Arch B Cell Pathol Incl Mol Pathol. 1984;45:197–219.View ArticlePubMedGoogle Scholar
  16. Molloy CJ, Laskin JD. Effect of retinoid deficiency on keratin expression in mouse bladder. Exp Mol Pathol. 1988;49:128–40.View ArticlePubMedGoogle Scholar
  17. Shetty P. Nutrition, immunity and infection. UK: Library of Congress Cataloging-in-Publication Data; 2010.View ArticleGoogle Scholar
  18. Sommer A, West KP, Olson JA, Ross AC. Vitamin A deficiency: health. New York: Survival and Vision. Oxford University Press; 1996.Google Scholar
  19. Villamor E, Fawzi WW. Effects of vitamin A supplementation on immune responses and correlation with clinical outcomes. Clin Microbiol Rev. 2005;18:446–64.View ArticlePubMedPubMed CentralGoogle Scholar
  20. Warden RA, Strazzari MJ, Dunkley PR, O’Loughlin EV. Vitamin A-deficient rats have only mild changes in jejunal structure and function. J Nutr. 1996;126:1817–26.PubMedGoogle Scholar
  21. Stephensen CB. Vitamin A, infection, and immune function. Annu Rev Nutr. 2001;21:167–92.View ArticlePubMedGoogle Scholar
  22. Twining SS, Schulte DP, Wilson PM, Fish BL, Moulder JE. Vitamin A deficiency alters rat neutrophil function. J Nutr. 1997;127:558–65.PubMedGoogle Scholar
  23. Karyadi E, Schultink W, Nelwan RHH, Gross R, Amin Z, Dolmans WMV, et al. Poor micronutrient status of active pulmonary tuberculosis patients in Indonesia. J Nutr. 2000;130:2953–8.PubMedGoogle Scholar
  24. Ramachandran G, Santha T, Garg R, Baskaran D, Iliayas SA, Venkatesan P, et al. Vitamin A levels in sputum-positive pulmonary tuberculosis patients in comparison with household contacts and healthy “normals”. Int J Tuberc Lung Dis. 2004;8:1130–3.PubMedGoogle Scholar
  25. Wiid I, Seaman T, Hoal EG, Benade AJS, Van Helden PD. Total antioxidant levels are low during active TB and rise with anti-tuberculosis therapy. IUBMB Life. 2004;56:101–6.View ArticlePubMedGoogle Scholar
  26. Ministère de la Santé. Manuel de reference du systeme d’information sanitaire du programme national de lutte antituberculeuse. 2016. http://www.sante.gov.ma/Documents/2016/02/Manuel%20de%20r%C3%A9f%C3%A9rence%20du%20SIS%20du%20PNLAT%20VF%2012%2002%202016.pdf. Accessed 16 Aug 2017.
  27. Granado-Lorencio F, Olmedilla-Alonso B, Herrero-Barbudo C, Blanco-Navarro I, Blázquez-García S, Pérez-Sacristán B. Simultaneous determination of vitamins A, E and 25-OH-vitamin D: application in clinical assessments. Clin Biochem. 2006;39:180–2.View ArticlePubMedGoogle Scholar
  28. de Pee S, Dary O. Biochemical indicators of vitamin A deficiency: serum retinol and serum retinol binding protein. J Nutr. 2002;132(9 Suppl):2895S–901S.PubMedGoogle Scholar
  29. WHO. WHO | Indicators for assessing vitamin A deficiency and their application in monitoring and evaluating intervention programmes. WHO. 1996. http://www.who.int/nutrition/publications/micronutrients/vitamin_a_deficiency/WHO_NUT_96.10/en/. Accessed 27 Dec 2015.
  30. Duester G. Retinoic acid synthesis and signaling during early organogenesis. Cell. 2008;134:921–31.View ArticlePubMedPubMed CentralGoogle Scholar
  31. D’Ambrosio DN, Clugston RD, Blaner WS. Vitamin A metabolism: an update. Nutrients. 2011;3:63–103.View ArticlePubMedPubMed CentralGoogle Scholar
  32. Ross AC. Cellular metabolism and activation of retinoids: roles of cellular retinoid-binding proteins. FASEB J. 1993;7:317–27.PubMedGoogle Scholar
  33. Wald G. Molecular basis of visual excitation. Science. 1968;162:230–9.View ArticlePubMedGoogle Scholar
  34. Ginawi IA. Effect of zinc and vitamin A supplementation along with intertubercular treatment in pulmonary tuberculosis in north Indian patients. Int J Pharm Sci Res. 2013;4(9):3426.Google Scholar
  35. Koyanagi A, Kuffó D, Gresely L, Shenkin A, Cuevas LE. Relationships between serum concentrations of C-reactive protein and micronutrients, in patients with tuberculosis. Ann Trop Med Parasitol. 2004;98:391–9.View ArticlePubMedGoogle Scholar
  36. Oh J, Choi R, Park H-D, Lee H, Jeong B-H, Park HY, et al. Evaluation of vitamin status in patients with pulmonary tuberculosis. J Infect. 2017;74:272–80.View ArticlePubMedGoogle Scholar
  37. Pakasi TA, Karyadi E, Wibowo Y, Simanjuntak Y, Suratih NMD, Salean M, et al. Vitamin A deficiency and other factors associated with severe tuberculosis in Timor and Rote Islands, East Nusa Tenggara Province, Indonesia. Eur J Clin Nutr. 2009;63:1130–5.View ArticlePubMedGoogle Scholar
  38. van Lettow M, Harries AD, Kumwenda JJ, Zijlstra EE, Clark TD, Taha TE, et al. Micronutrient malnutrition and wasting in adults with pulmonary tuberculosis with and without HIV co-infection in Malawi. BMC Infect Dis. 2004;4:61.View ArticlePubMedPubMed CentralGoogle Scholar
  39. Müller O, Krawinkel M. Malnutrition and health in developing countries. Can Med Assoc J. 2005;173:279–86.View ArticleGoogle Scholar
  40. Mitra AK, Alvarez JO, Stephensen CB. Increased urinary retinol loss in children with severe infections. Lancet Lond Engl. 1998;351:1033–4.View ArticleGoogle Scholar
  41. Mitra AK, Alvarez JO, Wahed MA, Fuchs GJ, Stephensen CB. Predictors of serum retinol in children with shigellosis. Am J Clin Nutr. 1998;68:1088–94.PubMedGoogle Scholar
  42. Stephensen CB, Alvarez JO, Kohatsu J, Hardmeier R, Kennedy JI, Gammon RB. Vitamin A is excreted in the urine during acute infection. Am J Clin Nutr. 1994;60:388–92.PubMedGoogle Scholar
  43. Filteau SM, Morris SS, Abbott RA, Tomkins AM, Kirkwood BR, Arthur P, et al. Influence of morbidity on serum retinol of children in a community-based study in northern Ghana. Am J Clin Nutr. 1993;58:192–7.PubMedGoogle Scholar
  44. Quadro L, Blaner WS, Salchow DJ, Vogel S, Piantedosi R, Gouras P, et al. Impaired retinal function and vitamin A availability in mice lacking retinol-binding protein. EMBO J. 1999;18:4633–44.View ArticlePubMedPubMed CentralGoogle Scholar
  45. Rosales FJ, Ross AC. A low molar ratio of retinol binding protein to transthyretin indicates vitamin A deficiency during inflammation: studies in rats and a posterior analysis of vitamin A-supplemented children with measles. J Nutr. 1998;128:1681–7.PubMedGoogle Scholar
  46. Tanumihardjo SA. Vitamin A: biomarkers of nutrition for development. Am J Clin Nutr. 2011;94:658S–65S.View ArticlePubMedPubMed CentralGoogle Scholar
  47. Ali W. Serum zinc levels and its association with vitamin A levels among tuberculosis patients. 2014. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3961917/?report=printable. Accessed 13 Dec 2015.
  48. Durán Alert P, Milà Villarroel R, Formiga F, Virgili Casas N, Vilarasau Farré C. Assessing risk screening methods of malnutrition in geriatric patients: mini Nutritional Assessment (MNA) versus geriatric nutritional risk index (GNRI). Nutr Hosp. 2012;27:590–8.PubMedGoogle Scholar
  49. Shakersain B, Santoni G, Faxén-Irving G, Rizzuto D, Fratiglioni L, Xu W. Nutritional status and survival among old adults: an 11-year population-based longitudinal study. Eur J Clin Nutr. 2016;70:320.View ArticlePubMedGoogle Scholar
  50. Darnton-Hill I, Webb P, Harvey PWJ, Hunt JM, Dalmiya N, Chopra M, et al. Micronutrient deficiencies and gender: social and economic costs. Am J Clin Nutr. 2005;81:1198S–205S.PubMedGoogle Scholar
  51. McLaren DS, Frigg M. Sight and life manual on vitamin A deficiency disorders (VADD). Commun Eye Health. 2000;13:28.Google Scholar
  52. Yadav RJ. Prevalence of vitamin A deficiency in Bihar: a gender perspective. Indian J Prev Med. 2006;37:4.Google Scholar
  53. Bini EI, Mata Espinosa D, Marquina Castillo B, Barrios Payán J, Colucci D, Cruz AF, et al. The influence of sex steroid hormones in the immunopathology of experimental pulmonary tuberculosis. PLoS ONE. 2014;9:e93831.View ArticlePubMedPubMed CentralGoogle Scholar
  54. Neyrolles O, Quintana-Murci L. Sexual inequality in tuberculosis. PloS Med. 2009;6:e1000199. doi:10.1371/journal.pmed.1000199.View ArticlePubMedPubMed CentralGoogle Scholar
  55. Nhamoyebonde S, Leslie A. Biological differences between the sexes and susceptibility to tuberculosis. J Infect Dis. 2014;209(Suppl 3):S100–6.View ArticlePubMedGoogle Scholar
  56. D’Agostino P, Milano S, Barbera C, Di Bella G, La Rosa M, Ferlazzo V, et al. Sex hormones modulate inflammatory mediators produced by macrophages. Ann NY Acad Sci. 1999;876:426–9.View ArticlePubMedGoogle Scholar
  57. Fox HS, Bond BL, Parslow TG. Estrogen regulates the IFN-gamma promoter. J Immunol Baltim Md. 1950;1991(146):4362–7.Google Scholar
  58. Zuckerman SH, Bryan-Poole N, Evans GF, Short L, Glasebrook AL. In vivo modulation of murine serum tumour necrosis factor and interleukin-6 levels during endotoxemia by oestrogen agonists and antagonists. Immunology. 1995;86:18–24.PubMedPubMed CentralGoogle Scholar
  59. Nashold FE, Spach KM, Spanier JA, Hayes CE. Estrogen controls vitamin D3-mediated resistance to experimental autoimmune encephalomyelitis by controlling vitamin D3 metabolism and receptor expression. J Immunol. 2009;183:3672–81.View ArticlePubMedGoogle Scholar

Copyright

© The Author(s) 2017

Advertisement